ASCO25

A Deep Dive Into the Most Important Lung Cancer Trials Presented at ASCO25 – IASLC

The International Association for the Study of Lung Cancer (IASLC) shared a post on LinkedIn:

“The newest episode of Lung Cancer Considered is part of the IASLC’s world-language podcast series and highlights key trial insights from a Japanese clinical perspective.

Dr. Misako Nagasaka is joined by Dr. Yasushi Goto and Dr. Yuko Oya for a deep dive into the most important lung cancer trials presented at ASCO25.

Featured studies include:

  • CheckMate 816
  • NEOADAURA
  • TROPION-Lung02
  • REZILIENT1
  • DeLLphi-304

Listen here:”

More posts featuring IASLC.

ASCO25 cancer IASLC Lung cancer Lung Cancer Considered Misako Nagasaka NSCLC OncoDaily Oncology Yasushi Goto Yuko Oya